|
噬菌体抗菌分子机制及临床应用研究进展
肖非 石瑛 黄加权 关键词：噬菌体;抗菌;hollin蛋白;内溶素;溶解蛋白
分类号：R978.1 文献标识码：A
文章编号：1008-049X(2006)08-0754-03
|
|
噬菌体(phage)是1917年由法国的d'Herelle率先发现的,它没有独立的代谢酶系,只能利用宿主细胞的生物合成机构进行核酸复制和蛋白合成以完成自身的增殖.除丝状噬菌体因其特殊的形态能从宿主逸出而不对宿主造成致命的后果外,其它所有噬菌体都在感染周期的晚期以特定的方式溶解宿主细胞,释放子代噬菌体颗粒去感染新的宿主.…… |
作者单位：肖非（华中科技大学同济医学院附属同济医院感染科,武汉,430030）
石瑛（华中科技大学同济医学院附属协和医院泌尿外科）
黄加权（华中科技大学同济医学院附属同济医院感染科,武汉,430030）
参考文献：
[1]Ry Young,Ing-Nang Wang,William D.Roof.Phage will out:strategies of host cell lysis[J].Trends in Microbiology,2000,8 (3):120-128
[2]Natasa Vukov,Siegfried Scherer,Loessner,et al.Functional analysis of.heterologous hollin proteins in a λS genetic background[J].FEMS Microbiol Lett,2000,184:179-186
[3]Angelika Gründing,Michael D,Manson,Ry Young.Holins kill without warning[J].PANS,2001,98(16):9348-9352
[4]John Deaton,Christos G Savva,Jingchuan Sun,et al.Solubilization and delivery by GroEL of megadalton complexes of the γ hollin[J].Protein Science,2004,13:1778-1786
[5]Ing-Nang Wang,John Deaton,Ry Young.Sizing the hollin lesion with an endolysin-β-galactosidase fusion[J].Journal of Bacteriology,2003,185 (3):779-787
[6]Anton Graschoft,Udo Blasi.Functional assembly of the lambda S hollin requires periplasmic localization of its N-terminus[J].Arch Microbiol,1999,172:31-39
[7]Thomas GB,Ing-Nang Wang,Douglas KS,et al.Breaking free:"Protein antibiotics" and phage lysis[J].Research in Microbiology,2002,153:493-501
[8]Thomas GB,Ing-Nang Wang,Douglas KS,et al.A protein antibiotic in the phage Q virion:Diversity in lysis targets[J].Science,2001,292:2326-2329
[9]E Ramanculov,R Young.Functional analysis of the phage T4 hollin in a lambda context[J].Mol Genet Genomics,2001,265:345-353
[10]D Nelson,Loomis,VA Fischetti.Prevention and elimination of upper respiratory colonization of mice by group a streptococci by using a bacteriophage lyric enzyme[J].Proc Natl Acad Sci,2001,98(8):4107-4112
[11]Robert JH Payne,Vincent AA Jansen.Phage therapy:the peculiar kinetics of self-replicating pharmaceuticals[J].Clin Pharmacol Ther,2000,68:225-230
[12]Robert JH Payne,Vincent AA Jansen.Understanding bacteriophage therapy as a density-dependent kinetic process[J].J Ther Biol,2001,208:37-48
[13]Angela Pirisi.Phage therapy-advantages over antibiotics[J].Lancet,2000,356:1418
[14]Ing-Nang Wang,D L Smith,Ryland Young.HOLINS:The Protein Clocks of Bacteriophage Infections[J].Annu Rev Microbiol,2000,54:799-825
[15]TG Bernhardt,DK Struck,R Young.The Lysis Protein E of X174 Is a Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis[J].J Biol Chem,2001,276(9):6093-6097
[16]TG Bernhardt,WD Roof,R.Young.Genetic evidence that the bacteriophage X174 lysis protein inhibits cell wall synthesis[J].Proc Nail Acad Sci USA,2000,97(8):4297-4302
[17]A Sulakvelidze,Z Alavidze,J Glenn Morres J.Bacteriophage Therapy[J].Antimicrobial Agents and Chemotherapy,2001,45:649-659
[18]Carlton RM Phage therapy:Past history and future prospects[J].Arch Immunol Ther Exp (Warsz),1999,47(5):267-274
[19]CG Takada,R Salavati,S Altman.Phenotypic conversion of drug-resistant bacteria to drug sensitivity[J].Proc Natl Acad Sci USA,1997,94:8468-8472
[20]Payne RJ,Phil D,Jansen VA.Phage therapy:the peculiar kinetics of selfreplicating pharmaceuticals[J].Clin Pharmacol Ther,2000,68(3):225-30
[21]孙伟,朱春宝.噬菌体治疗细菌感染的研究[J].国外医药抗生素分册,2005,26(2):54-58
[22]范秀珍,王华杰.革兰阳性杆菌耐药性变迁与抗菌药物使用量相关性分析[J].药物流行病学杂志,2003,12(6):313-315
[23]顾觉奋.加强抗生素监管促进合理用药[J].中国药师,2005,8(2):110-112
|
收稿日期：2005年6月22日
修稿日期：2006年3月10日
出版日期：2006年8月5日 | 资料来自:中国药师-专业站 |
|